CVC Capital Partners (CVC), through CVC Capital Partners VIII, is to acquire a co-controlling holding in FutureLife, a pan-European IVF provider, alongside the company’s current investor Hartenberg Holding (Hartenberg).
Headquartered in Prague, Czech Republic, FutureLife is a leading Pan-European provider of IVF and related genetics services, with presence across eight European markets including Czech Republic, Ireland, Netherlands, Finland, Romania and Estonia. FutureLife has 42 well-invested clinics and performs in excess of 39,000 IVF cycles annually, IVF add-on and laboratory services, as well as a series of biological and surgical treatments.
Read more/Source: Private Equity Wire
